Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionXponance, Inc.
Latest Disclosed Ownership20,603 shares
Latest Disclosed Value $ 2,003,642
Xponance, Inc. reports 133.44% increase in ownership of RVMD / Revolution Medicines, Inc.

On May 13, 2026 - Xponance, Inc. filed a 13F-HR form disclosing ownership of 20,603 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $2,003,642 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 8,826 shares of Revolution Medicines, Inc.. This represents a change in shares of 133.44% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 20,603 11,777 133.44 2,004 185.33 0.0142
2026-02-12 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 8,826 307 3.60 703 76.83 0.0053
2025-11-12 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 8,519 14 0.16 398 27.24 0.0032
2025-08-14 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 8,505 -4,432 -34.26 313 -31.73 0.0026
2025-05-01 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 12,937 810 6.68 457 -13.77 0.0044
2025-02-11 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 12,127 2,140 21.43 530 17.26 0.0048
2024-11-12 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 9,987 336 3.48 453 20.86 0.0044
2024-08-14 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 9,651 1,175 13.86 375 37.00 0.0038
2024-05-13 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 8,476 -252 -2.89 273 9.20 0.0029
2024-01-31 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 8,728 8,728 250 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.